Smartfish in CVD study
Smartfish medical nutritional drinks will be used in a study at Jagiellonian University in Krakow in Poland.
Added on 11th Jun 2012
Smartfish medical nutritional drinks will be used in a study lead by Grzegorz Gajos, professor of cardiology at Jagiellonian University in Krakow in Poland.
The study aims to evalute the effects of Omega 3 PUFA administered on top of optimal therapy of atherosclerotic vascular disease and type 2 Diabetes on endothelial function, platelet aggregation and thrombotic, inflammatory and oxidative stress biomarkers; risk parameters of cardiovascular events.
The study is sponsored by the Polish National Science Centre. Smartfish contributes with study medicine as an unrestricted grant.